GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk

Background GlycA is a novel spectroscopic marker of systemic inflammation with low intra-individual variability and other attributes favoring its clinical use in patients with chronic inflammatory and autoimmune diseases. GlycA is unique in its composite nature, reflecting both increased glycan comp...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of translational medicine Vol. 15; no. 1; pp. 219 - 5
Main Authors:	Connelly, Margery A., Otvos, James D., Shalaurova, Irina, Playford, Martin P., Mehta, Nehal N.
Format:	Journal Article
Language:	English
Published:	London BioMed Central 27.10.2017 BioMed Central Ltd Springer Nature B.V BMC
Subjects:	Acetylglucosamine - blood Biological markers Biomarkers - blood Biomedical and Life Sciences Biomedicine C-Reactive Protein - metabolism Cardiovascular Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - blood Cardiovascular Diseases - mortality GlycA Health aspects Health risk assessment Humans Identification and classification Inflammation Inflammation - blood Medicine/Public Health Metabolic and Lipoprotein Translation Mortality NMR Nuclear magnetic resonance Nuclear magnetic resonance spectroscopy Review Risk Factors Nuclear magnetic resonance spectroscopy GlycA Cardiovascular disease Inflammation
ISSN:	1479-5876, 1479-5876
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!